Clinical Trial Detail

NCT ID NCT01104922
Title Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Age Groups: adult

No variant requirements are available.